• New Studies with Xeloda (capecitabine) in Colorectal Cancer Treatment Presented at First-Ever GI Cancer Symposium
    SAN FRANCISCO  -- A series of studies presented today at the first-ever Gastrointestinal Cancers Symposium show the combination of Xeloda (capecitabine) -- a pill-form of chemotherapy -- and irinotecan to be active and generally well-tolerated as a first-line treatment ...More
    February 6, 2004 Posted in News, Disorders, Industry Issues, Procedures
  • Medical Devices Can Cause Woes
    Salt Lake City - Medical "errors" don't just involve giving a wrong medication, the wrong dose or causing an allergic reaction -- malfunctioning or poorly installed medical devices can harm patients, too. But it's a lot harder to identify those events and thus prevent ...More
    February 6, 2004 Posted in News, Industry Issues
  • Biopsy with Needle, Not Scalpel
    Endoscopic ultrasound (EUS) can visualize solid masses in the pancreas better than conventional ultrasound or CT scans, but its ability to differentiate between cancer and inflammatory masses is limited. UAB gastroenterologist Mohamad A. Eloubeidi, M.D., reported in ...More
    February 6, 2004 Posted in News, Disorders, Industry Issues
  • SRI/Surgical Express Performs Groundbreaking Installation of RFID Technology
    TAMPA, Fla.— SRI/Surgical Express, Inc. (SRI), a provider of products and services supporting the healthcare industry, has announced the successful implementation of Radio Frequency Identification (RFID) Technology in all 10 of its processing facilities across the United ...More
    February 4, 2004 Posted in News, Industry Issues
  • Inflammation Marker Predicts Colon Cancer
    C-reactive protein (CRP) -- a marker of inflammation circulating in the blood already associated with increased risk of heart disease -- can also be used to identify a person's risk of developing colon cancer, according to a Johns Hopkins study.Results of the study, ...More
    February 4, 2004 Posted in News, Disorders, Industry Issues, Procedures
  • Study Quantifies Cancer Risk from Diagnostic X-Rays
    The most detailed calculation of its kind to estimate the risk of cancer from exposure to diagnostic X-rays recently published in THE LANCET suggests that in the UK around 700 of the 124,000 cases of cancer diagnosed annually could be attributable to exposure to ...More
    February 2, 2004 Posted in News, Disorders, Industry Issues
  • Researchers Discover that A Virus Can Naturally Target and Kill Tumors
    Mosquitoes are notorious for their ability to spread disease, but in some cases they may prove to be a boon instead of a bane. In a recent study, researchers at New York University School of Medicine found that one mosquito-borne virus automatically targets and kills tumor ...More
    February 2, 2004 Posted in News, Disorders, Industry Issues
  • Pharma Update
    Shame. Embarrassment. Humiliation. These are just a handful of descriptors for the feelings experienced by individuals with fecal incontinence. More than 6.5 million Americans have this condition — affecting children as well as adults. Fecal incontinence is the involuntary ...More
    February 1, 2004 Posted in Articles, Disorders
  • Look! There at the keyboard!
    Typing faster than a person should! Extracting information from those in the know! Able to spell “cholangeopancreatography” without the aid of a dictionary! It’s a mild-mannered reporter… it’s a new managing editor… it’s ENDOMAN! Fate has landed me smack dab in the world of ...More
    February 1, 2004 Posted in Articles
  • The Evolution of ERCP
    ERCP has evolved from diagnostic tool to therapeutic alternative. While technological advancements and new techniques have enhanced ease and speed, the procedure still carries risks. Photo courtesy of Pentax Endoscopic retrograde cholangiopancreatography (ERCP) is evolving ...More
    February 1, 2004 Posted in Articles, Disorders, Industry Issues